Metabolic Syndrome and Diabetes Type 2 in Patients Cared for at a Nutrition Out-patient Facility in the City of Rio de Janeiro, R JPatrícia Passos Simões1,2*, Cristiane Barbosa Chagas2,3, Viviane Monteiro Dias2, Juliana Pandini Castelpoggi2, Renan Moritz Varnier Rodrigues de Almeida4 and Rosângela Peluso de Campos Furtado5
- *Corresponding Author:
- Patrícia Passos Simões
Rua Scylla Souza Ribeiro, n. 57/ apt. 102/ Bloco 4/ Itaipú
Niterói, RJ, 24210 510, Brazil
Tel: 55 21 3903 7130 / 9218 5696
E-mail: [email protected]
Received date: May 03, 2013; Accepted date: June 18, 2013; Published date: June 25, 2013
Citation: Simões PP, Chagas CB, Dias VM, Castelpoggi JP, Rodrigues de Almeida RMV, et al. (2013) Metabolic Syndrome and Diabetes Type 2 in Patients Cared for at a Nutrition Out-patient Facility in the City of Rio de Janeiro, RJ. J Diabetes Metab S13:005. doi:10.4172/2155-6156.S13-005
Copyright: © 2013 Simões PP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background: Metabolic syndrome (MetS) is a complex disorder with a worldwide increasing prevalence. Most patients with Diabetes Mellitus type 2 (DM2) present MetS components such as overweigh/obesity, hypertension, dyslipidemia and hyperinsulinemia. However, population-based data, and more specifically Brazilian data on the subject are scarce, thus creating an interest in characterizing MetS factors in DM2 patients. Therefore, the objective of the present study was to describe the profile of diabetes mellitus type 2 patients (DM2) and to identify the presence of metabolic syndrome in this group.
Methods: Information was collected from the medical records of 127 patients who had a diagnostic of DM2 for at least two year. Biochemical (cholesterol, HDL, LDL, triglycerides, glucose, A1c, urea, creatinine and uric acid) and anthropometrical (weight, height and BMI) parameters and blood pressure were obtained. Patients were classified relatively to the presence of MetS.
Results: Dyslipidemia was present in 42.5% of the patients (n=54). When evaluating the BMI, mean value was 29.7 Kg/m2 (± 5.9). Mean and standard deviation values of fasting glucose were above normal (125.2 ± 45.4 mg/dL), and for LDL 101.6 ± 40,1 mg/dL. In the studied population, the prevalence of MetS was approximately 32%.
Conclusion: Poor glycemic control, hypertension and overweight were highly prevalent in the studied population. Better preventive measures are urgently needed for their control.